Maze Therapeutics, Inc.
MAZE
$41.49
$4.2211.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 383.94M | 264.54M | 294.37M | 196.81M | 149.61M |
| Total Receivables | 700.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.67M | 6.61M | 5.33M | 4.86M | 4.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 100.00K |
| Total Current Assets | 391.30M | 271.15M | 299.71M | 201.67M | 153.96M |
|
|
|||||
| Total Current Assets | 391.30M | 271.15M | 299.71M | 201.67M | 153.96M |
| Net Property, Plant & Equipment | 26.46M | 27.71M | 28.80M | 29.92M | 30.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.30M | 4.66M | 4.34M | 8.95M | 7.59M |
| Total Assets | 422.06M | 303.52M | 332.84M | 240.54M | 192.48M |
|
|
|||||
| Total Accounts Payable | 2.92M | 3.67M | 2.40M | 1.94M | 1.02M |
| Total Accrued Expenses | 14.43M | 11.52M | 11.54M | 14.10M | 11.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.76M | 4.72M | 4.67M | 4.63M | 4.62M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 217.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 217.00K |
| Total Current Liabilities | 22.11M | 19.90M | 18.62M | 20.67M | 17.56M |
|
|
|||||
| Total Current Liabilities | 22.11M | 19.90M | 18.62M | 20.67M | 17.56M |
| Long-Term Debt | -- | -- | -- | -- | 51.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.42M | 20.29M | 21.15M | 22.00M | 22.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.09M | 1.09M | 1.01M | 969.00K | 1.01M |
| Total Liabilities | 42.62M | 41.28M | 40.77M | 43.64M | 93.11M |
|
|
|||||
| Common Stock & APIC | 834.35M | 687.13M | 683.28M | 47.24M | 29.34M |
| Retained Earnings | -454.98M | -424.89M | -391.21M | -358.43M | -313.88M |
| Treasury Stock & Other | 69.00K | -- | -- | -- | -- |
| Total Common Equity | 379.44M | 262.24M | 292.07M | -311.18M | -284.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 508.09M | 383.90M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 508.09M | 383.90M |
|
|
|||||
| Total Common Equity | 379.44M | 262.24M | 292.07M | -311.18M | -284.53M |
| Total Preferred Equity | -- | -- | -- | 508.09M | 383.90M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 379.44M | 262.24M | 292.07M | 196.90M | 99.37M |
|
|
|||||